{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:16:01Z","timestamp":1768911361896,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerepidemiology.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.canep.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T01:41:14Z","timestamp":1436319674000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-597X","authenticated-orcid":false,"given":"Nut","family":"Koonrungsesomboon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita Carolle","family":"Wadagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-3769","authenticated-orcid":false,"given":"Evaristus Chibunna","family":"Mbanefo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0470","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1371\/journal.pntd.0000430","article-title":"Africa's 32 cents solution for HIV\/AIDS","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0475","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jare.2013.06.007","article-title":"Schistosomiasis and cancer in Egypt: review","volume":"4","author":"Khaled","year":"2013","journal-title":"J. Adv. Res."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0480","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.urolonc.2009.09.017","article-title":"Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium","volume":"29","author":"Botelho","year":"2011","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0485","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/era.12.49","article-title":"Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer","volume":"12","author":"Zaghloul","year":"2012","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"9","key":"10.1016\/j.canep.2015.06.004_bib0490","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/15216540400013903","article-title":"Cell cycle regulators in bladder cancer: relationship to schistosomiasis","volume":"56","author":"Eissa","year":"2004","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canep.2015.06.004_bib0495","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-9966-28-27","article-title":"Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors","volume":"28","author":"Abdulamir","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6326","key":"10.1016\/j.canep.2015.06.004_bib0500","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0505","first-page":"761","article-title":"The clinical relevance of urinary soluble fas (sFas) for diagnosis of bilharzial bladder cancer","volume":"7","author":"Eissa","year":"2013","journal-title":"Asian Biomed."},{"issue":"18","key":"10.1016\/j.canep.2015.06.004_bib0510","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/jnci\/87.18.1383","article-title":"High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder","volume":"87","author":"Gonzalez-Zulueta","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0515","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-4608(99)00040-0","article-title":"Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization","volume":"114","author":"Aly","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-4608(01)00527-1","article-title":"Chromosomal aberrations in early-stage bilharzial bladder cancer","volume":"132","author":"Aly","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0525","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ajcp\/106.2.234","article-title":"Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization","volume":"106","author":"Ghaleb","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"issue":"3 Pt 1","key":"10.1016\/j.canep.2015.06.004_bib0530","first-page":"737","article-title":"Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization","volume":"160","author":"Pycha","year":"1998","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.canep.2015.06.004_bib0535","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4172\/1948-5956.1000226","article-title":"The etiology of bladder cancer and its prevention","volume":"5","author":"Chung","year":"2013","journal-title":"J. Cancer Sci. Ther."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0540","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1078-1439(02)00271-5","article-title":"Cytokeratin 20, AN43 PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder","volume":"21","author":"Gee","year":"2003","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0545","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ncpuro0510","article-title":"Mechanisms of disease: the epidemiology of bladder cancer","volume":"3","author":"Pelucchi","year":"2006","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0550","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12291-012-0266-z","article-title":"Urinary tumor markers could predict survival in bladder carcinoma","volume":"28","author":"Salama","year":"2013","journal-title":"Indian J. Clin. Biochem."},{"issue":"9","key":"10.1016\/j.canep.2015.06.004_bib0555","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.humpath.2004.05.002","article-title":"Prognostic factors in Bilharzial-related bladder cancer","volume":"35","author":"Susani","year":"2004","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0560","first-page":"217","article-title":"Tumor marker determination in tissues and serum in bladder cancer patients both bilharzial and non-bilharzial","volume":"3","author":"Wahab Ragaa","year":"1988","journal-title":"J. Tumor Marker Oncol."},{"issue":"7","key":"10.1016\/j.canep.2015.06.004_bib0565","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1464-410X.2012.10949.x","article-title":"Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder","volume":"110","author":"Youssef","year":"2012","journal-title":"BJU Int."},{"issue":"7","key":"10.1016\/j.canep.2015.06.004_bib0570","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.canep.2015.06.004_bib0575","doi-asserted-by":"crossref","first-page":"e3164","DOI":"10.1371\/journal.pntd.0003164","article-title":"Host determinants of reinfection with schistosomes in humans: a systematic review and meta-analysis","volume":"8","author":"Mbanefo","year":"2014","journal-title":"PLOS Negl. Trop. Dis."},{"key":"10.1016\/j.canep.2015.06.004_bib0580","series-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","author":"Deeks","year":"2008"},{"issue":"7414","key":"10.1016\/j.canep.2015.06.004_bib0585","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.canep.2015.06.004_bib0590","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0595","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"12","key":"10.1016\/j.canep.2015.06.004_bib0600","doi-asserted-by":"crossref","first-page":"e3329","DOI":"10.1371\/journal.pntd.0003329","article-title":"P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection","volume":"8","author":"Santos","year":"2014","journal-title":"PLOS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00190555","article-title":"p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions","volume":"424","author":"Kamel","year":"1994","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0610","first-page":"531","article-title":"Alterations affecting the p53 control pathway in bilharzial-related bladder cancer","volume":"3","author":"Osman","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0615","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1464-410X.1997.30717.x","article-title":"Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder","volume":"79","author":"Chaudhary","year":"1997","journal-title":"Br. J. Urol."},{"issue":"2\u20133","key":"10.1016\/j.canep.2015.06.004_bib0620","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clinbiochem.2010.09.028","article-title":"Molecular markers and bladder carcinoma: schistosomal and non-schistosomal","volume":"44","author":"Shaker","year":"2011","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.canep.2015.06.004_bib0625","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.clinbiochem.2008.12.025","article-title":"Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis","volume":"42","author":"Shaker","year":"2009","journal-title":"Clin. Biochem."},{"issue":"3 Pt 1","key":"10.1016\/j.canep.2015.06.004_bib0630","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.juro.2007.05.006","article-title":"Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer","volume":"178","author":"Eissa","year":"2007","journal-title":"J. Urol."},{"issue":"1.","key":"10.1016\/j.canep.2015.06.004_bib0635","article-title":"Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis","volume":"6","author":"Elmansy","year":"2012","journal-title":"ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0640","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0304-3835(97)00314-5","article-title":"Glutathione S-transferase activity and glutathione content in human bladder carcinoma associated with schistosomiasis: comparison with uninvolved surrounding tissues","volume":"121","author":"Hassan","year":"1997","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0645","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365599709070301","article-title":"Expression of glutathione S-transferase activity and glutathione content in squamous cell carcinoma of bladder associated with schistosomiasis in a population in Egypt","volume":"31","author":"Ghazaly","year":"1997","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1016\/j.canep.2015.06.004_bib0650","doi-asserted-by":"crossref","first-page":"165879","DOI":"10.1155\/2012\/165879","article-title":"Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer","volume":"2012","author":"Thanan","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0655","first-page":"60","article-title":"Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer","volume":"10","author":"Hammam","year":"2008","journal-title":"Medscape J. Med."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0660","doi-asserted-by":"crossref","DOI":"10.1186\/1750-9378-8-9","article-title":"Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients","volume":"8","author":"Hassan","year":"2013","journal-title":"Infect. Agents Cancer"},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0665","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2011.09.073","article-title":"damage and Oct3\/4 expression in urinary bladder cancer with Schistosoma haematobium infection","volume":"414","author":"Ma","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0670","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<789::AID-IJC3>3.0.CO;2-C","article-title":"Biomonitoring of N-nitroso compounds, nitrite and nitrate in the urine of Egyptian bladder cancer patients with or without Schistosoma haematobium infection","volume":"82","author":"Abdel Mohsen","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0675","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/carcin\/10.3.547","article-title":"Urinary excretion of nitrate, nitrite and N-nitroso compounds in Schistosomiasis and bilharzia bladder cancer patients","volume":"10","author":"Tricker","year":"1989","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0680","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopha.2012.10.019","article-title":"Is there a correlation between HPV and urinary bladder carcinoma?","volume":"67","author":"Shaker","year":"2013","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0685","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3923\/pjbs.2011.212.218","article-title":"Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer","volume":"14","author":"Ghaleb","year":"2011","journal-title":"Pak. J. Biol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.canep.2015.06.004_bib0690","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-8981(00)00317-X","article-title":"Deletion of p16 and p15 genes in schistosomiasis-associated bladder cancer (SABC)","volume":"300","author":"Eissa","year":"2000","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.canep.2015.06.004_bib0695","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/modpathol.3800177","article-title":"CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer","volume":"17","author":"Gutierrez","year":"2004","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.canep.2015.06.004_bib0700","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinbiochem.2004.09.006","article-title":"Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression","volume":"37","author":"Swellam","year":"2004","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0705","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<183::AID-IJC7>3.0.CO;2-U","article-title":"Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder C","volume":"68","author":"Tamimi","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0710","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1309\/AJCP76KUVOTBKQRY","article-title":"Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers","volume":"135","author":"Kapur","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0715","first-page":"1","article-title":"Loss of maspin expression in bladder cancer: its relationship with p53 and clinicopathological parameters","volume":"22","author":"Abd El-Maqsoud","year":"2010","journal-title":"J. Egypt Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0720","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.humpath.2010.07.012","article-title":"Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder","volume":"42","author":"Youssef","year":"2011","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0725","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02893365","article-title":"Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors","volume":"12","author":"Helal","year":"2006","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0730","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1078-1439(03)00014-0","article-title":"Correlation between p53 mutations and HPV in bilharzial bladder cancer","volume":"21","author":"Khaled","year":"2003","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0735","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/16.5.1181","article-title":"Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours","volume":"16","author":"Warren","year":"1995","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0740","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s12032-009-9375-9","article-title":"Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence","volume":"27","author":"Eissa","year":"2010","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0745","first-page":"68","article-title":"P27 and mdm2 as molecular grading biomarkers in transitional cell carcinoma","volume":"38","author":"El-Abd","year":"2008","journal-title":"Turk. J. Cancer"},{"issue":"3\u20134","key":"10.1016\/j.canep.2015.06.004_bib0750","first-page":"317","article-title":"Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer","volume":"59","author":"Eissa","year":"2013","journal-title":"Clin. Lab."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0755","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0302-2838(03)00417-2","article-title":"Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer","volume":"44","author":"Eissa","year":"2003","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0760","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1078-1439(00)00127-7","article-title":"Telomerase activity in bilharzial bladder cancer: prognostic implications","volume":"6","author":"Abdel-Salam","year":"2001","journal-title":"Urol. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0765","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/01913123.2011.651522","article-title":"CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer","volume":"36","author":"Omran","year":"2012","journal-title":"Ultrastruct. Pathol."},{"issue":"16\u201317","key":"10.1016\/j.canep.2015.06.004_bib0770","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.clinbiochem.2008.08.085","article-title":"Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer","volume":"41","author":"Eissa","year":"2008","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0775","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1464-410X.2004.04575.x","article-title":"Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers","volume":"93","author":"Gadalla","year":"2004","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0780","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.clinbiochem.2012.01.010","article-title":"Urinary retinoic acid receptor-beta2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer","volume":"45","author":"Eissa","year":"2012","journal-title":"Clin. Biochem."},{"issue":"8","key":"10.1016\/j.canep.2015.06.004_bib0785","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1158\/1055-9965.EPI-11-0237","article-title":"Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer","volume":"20","author":"Eissa","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9","key":"10.1016\/j.canep.2015.06.004_bib0790","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.clinbiochem.2004.05.027","article-title":"Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma","volume":"37","author":"Eissa","year":"2004","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0795","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-014-9765-y","article-title":"Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer","volume":"20","author":"Shabayek","year":"2014","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0800","first-page":"260","article-title":"Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder","volume":"17","author":"Abdel Wahab","year":"2005","journal-title":"J. Egypt Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0805","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-4608(99)00126-0","article-title":"Loss of Y chromosome in bilharzial bladder cancer","volume":"117","author":"Khaled","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"issue":"7","key":"10.1016\/j.canep.2015.06.004_bib0810","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/cncr.20902","article-title":"Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs","volume":"103","author":"Eissa","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.canep.2015.06.004_bib0815","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0009-9120(02)00382-X","article-title":"Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients","volume":"35","author":"El-Salahy","year":"2002","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.canep.2015.06.004_bib0820","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.juro.2010.10.036","article-title":"Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder","volume":"185","author":"Youssef","year":"2011","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0825","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1464-410X.2010.09854.x","article-title":"Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression","volume":"108","author":"Youssef","year":"2011","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0830","first-page":"56","article-title":"E-cadherin in relation with the proliferating cell nuclear antigen of the bilharzia associated and non-associated urinary bladder carcinoma","volume":"29","author":"Rashed","year":"2004","journal-title":"Iran. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0835","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0022-5347(05)64659-9","article-title":"Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors","volume":"168","author":"Eissa","year":"2002","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0840","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.urolonc.2004.07.016","article-title":"Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization","volume":"22","author":"Aly","year":"2004","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0845","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clinbiochem.2004.09.004","article-title":"HER2\/neu expression in bladder cancer: relationship to cell cycle kinetics","volume":"38","author":"Eissa","year":"2005","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0850","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12032-013-0804-4","article-title":"Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis","volume":"31","author":"Eissa","year":"2014","journal-title":"Med. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.canep.2015.06.004_bib0855","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clinbiochem.2013.10.022","article-title":"Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis","volume":"47","author":"Eissa","year":"2014","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0860","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.arcmed.2005.04.019","article-title":"Elevation of hyaluronidase-1 and soluble intercellular adhesion molecule-1 helps select bladder cancer patients at risk of invasion","volume":"37","author":"Aboughalia","year":"2006","journal-title":"Arch. Med. Res."},{"issue":"7\u20138","key":"10.1016\/j.canep.2015.06.004_bib0865","first-page":"893","article-title":"The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer","volume":"59","author":"Eissa","year":"2013","journal-title":"Clin. Lab."},{"key":"10.1016\/j.canep.2015.06.004_bib0870","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2490-13-25","article-title":"Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer","volume":"13","author":"Mohammed","year":"2013","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.canep.2015.06.004_bib0875","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1155\/2013\/341578","article-title":"The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine","volume":"34","author":"Eissa","year":"2013","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0880","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/iub.325","article-title":"Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer","volume":"62","author":"Eissa","year":"2010","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.canep.2015.06.004_bib0885","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1084\/jem.12.5.696","article-title":"A transmissible avian neoplasm (sarcoma of the common fowl)","volume":"12","author":"Rous","year":"1910","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0890","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/0255-0857.16044","article-title":"Association of parasitic infections and cancers","volume":"23","author":"Khurana","year":"2005","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.canep.2015.06.004_bib0895","first-page":"9","volume":"vol. 61","author":"IARC.","year":"1994"},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0900","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2010.07.008","article-title":"Helminths in human carcinogenesis","volume":"305","author":"Fried","year":"2011","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.canep.2015.06.004_bib0905","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0027-5107(94)90248-8","article-title":"Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients","volume":"305","author":"Rosin","year":"1994","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.canep.2015.06.004_bib0910","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<598::AID-IJC25>3.0.CO;2-0","article-title":"Nitrate, nitrite and N-nitroso compounds in human bladder cancer associated with schistosomiasis","volume":"86","author":"Badawi","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"84","key":"10.1016\/j.canep.2015.06.004_bib0915","first-page":"384","article-title":"N-nitrosamine formation in urinary-tract infections","author":"Ohshima","year":"1987","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.canep.2015.06.004_bib0920","first-page":"2","article-title":"Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization","author":"Fadl-Elmula","year":"2002","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0925","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.urolonc.2004.07.015","article-title":"Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis","volume":"22","author":"Khaled","year":"2004","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2015.06.004_bib0930","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4161\/cbt.4.6.1765","article-title":"Analysis of fibronectin expression in the bilharzial granulomas and of laminin in the transformed urothelium in Schistosoma haematobium infested patients","volume":"4","author":"Hussein","year":"2005","journal-title":"Cancer Biol. Ther."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782115001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T22:08:34Z","timestamp":1717970914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782115001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1877782115001320"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2015.06.004","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}